Education
About Us
Working with TipRanks
Follow Us
Intuitive Surgical (ISRG)
NASDAQ:ISRG
ISRG Stock Chart & Stats
$478.49
$11.55(2.17%)
At close: 4:00 PM EST
$478.49
$11.55(2.17%)
Day’s Range― - ―
52-Week Range$425.00 - $609.08
Previous CloseN/A
Volume485.62K
Average Volume (3M)1.70M
Market Cap
$169.93B
Enterprise Value$168.72B
Total Cash (Recent Filing)$4.91B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)60.8
Beta1.16
Next Earnings
Apr 21, 2026EPS Estimate
2.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.53
Shares Outstanding354,496,060
10 Day Avg. Volume2,345,496
30 Day Avg. Volume1,696,789
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)11.28
Price to Sales (P/S)22.20
P/FCF Ratio142.20
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue17.55
Enterprise Value/Gross Profit26.43
Enterprise Value/Ebitda47.11
Forecast
1Y Price Target
$652.73Price Target Upside36.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
EPS Forecast (FY)10.05
Revenue Forecast (FY)$11.52B
Bulls Say, Bears Say
Bulls Say
Advanced Imaging And Intraoperative GuidanceDevelopment of dye-free real-time tissue oxygenation imaging using hyperspectral techniques promises quantitative metrics that could improve surgical outcomes and accelerate adoption of imaging-enabled platforms.
Product Launch And Fleet UpgradesNew Dv5 system launch is expected to prompt hospitals to upgrade existing robots and expand robotic fleets, increasing demand for systems and related instruments and accessories.
Regulatory Expansion Of Clinical UsesRegulatory clearance enabling cardiac procedures on the latest surgical platform broadens clinical use cases and enlarges the addressable market for the company’s systems.
Bears Say
International Exposure And Procedure Guidance RiskExposure to specific international markets and potential tariff impacts, together with guidance for slower procedure growth, could constrain procedure volume expansion and pressure margins outside the domestic market.
Trade-in Dynamics And Unit Growth RiskRising trade-in activity and refurbished placements may reduce net new system placements even if gross shipments appear healthy, creating pressure on unit growth metrics.
Valuation PremiumRich valuation compared with large medical device peers raises expectations and increases downside risk if future growth or execution falls short.
Intuitive Surgical News
ISRG FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest stock price was $425.00 and its highest was $609.08 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $169.93B.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Apr 21, 2026 which is in 75 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Jan 22, 2026. The company reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.267 by $0.263.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical does not currently pay dividends.
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 2.13.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 354,496,060 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of $2.53 in its last earnings report, beating expectations of $2.267. Following the earnings report the stock price went down -0.346%.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in ISRG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Intuitive Surgical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$652.73 (36.41% Upside)
$652.73 (36.41% Upside)
Blogger Sentiment
Bullish
ISRG Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 517.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 4.5%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.45%
12-Months-Change
Fundamentals
Return on Equity
16.67%
Trailing 12-Months
Asset Growth
9.52%
Trailing 12-Months
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
ISRG Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call described strong top-line and procedure growth, meaningful increases in cash flow and profitability, rapid adoption of new platforms (da Vinci 5, SP, Ion), and continued product and clinical progress. Offsetting these positives are margin pressures from tariffs and product mix, elevated operating expenses (including a large foundation donation and hiring), competitive pricing/tender dynamics in China, placement softness in Japan, and lower Ion placements in Q4. On balance the company reported multiple high-growth metrics and solid cash generation while outlining manageable but notable near-term headwinds.View all ISRG earnings summariesISRG Revenue Breakdown
67.72% U.S.
32.28% Outside of U.S
ISRG Stock 12 Month Forecast
Average Price Target
$652.73
▲(36.41% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Hologic
―
Resmed
―
West Pharmaceutical Services
―
Ownership Overview
0.45% Insiders
22.59% Mutual Funds
0.87% Other Institutional Investors
50.76% Public Companies and Individual Investors